Opportunity
SAM #7571TE27Q00054
HHS request for Clarivate Cortellis subscriptions, with related NIH/NCATS sole-source notice
Buyer
Department of Health and Human Services
Posted
November 16, 2026
Respond By
November 20, 2026
Identifier
7571TE27Q00054
NAICS
541519, 513210
HHS is seeking subscriptions to Clarivate’s Cortellis research and safety-intelligence products for a base year and two option years. - Requirement - Cortellis Drug Discovery Intelligence: 3 named-user, limited licenses per year. - OFF-X (Translational Safety/Toxicology): 2 named-user, limited licenses per year. - The same quantities are listed for the base year and both option periods. - Agency and sourcing - The detailed subscription request is from HHS, OMAS Information Technology. - A related NIH/NCATS notice describes an intent to sole-source the Clarivate Cortellis licenses from DR/Decision Resources LLC, identified as the only known responsible source. Clarivate is the product OEM. - Interested organizations were invited to submit capability statements and pricing by 11:00 AM EST, November 20, 2026. - Evaluation and invoicing - The HHS request specifies a Lowest Priced Technically Acceptable evaluation. - Invoices are paid monthly in arrears through the Invoice Processing Platform (IPP). - Contract term - Base: December 18, 2026–December 17, 2027. - Option 1: December 18, 2027–December 17, 2028. - Option 2: December 18, 2028–December 17, 2029. - Unspecified details - No part numbers or subscription prices are provided. The notice does not state the value of the opportunity.
Description
Software Licenses for Clarivate Cortellis